Last reviewed · How we verify

Period 2: carbamazepine

Atea Pharmaceuticals, Inc. · Phase 1 active Small molecule

Period 2: carbamazepine is a Small molecule drug developed by Atea Pharmaceuticals, Inc.. It is currently in Phase 1 development.

At a glance

Generic namePeriod 2: carbamazepine
SponsorAtea Pharmaceuticals, Inc.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Period 2: carbamazepine

What is Period 2: carbamazepine?

Period 2: carbamazepine is a Small molecule drug developed by Atea Pharmaceuticals, Inc..

Who makes Period 2: carbamazepine?

Period 2: carbamazepine is developed by Atea Pharmaceuticals, Inc. (see full Atea Pharmaceuticals, Inc. pipeline at /company/atea-pharmaceuticals-inc).

What development phase is Period 2: carbamazepine in?

Period 2: carbamazepine is in Phase 1.

Related